Related Experiment Videos
DNA-polymerase inhibitors. Rifamycin derivatives
Nucleic Acids Research
|March 1, 1977
Summary
New rifamycin derivatives show potent DNA polymerase inhibition. One derivative selectively targets viral reverse transcriptase, offering potential for antiviral drug development.
Area of Science:
- Medicinal Chemistry
- Molecular Biology
- Biochemistry
Background:
- Rifamycin derivatives are known for their biological activities.
- DNA polymerases are crucial enzymes in DNA replication and are targets for antimicrobial and antiviral therapies.
Purpose of the Study:
- To synthesize novel rifamycin derivatives with modifications at position 3.
- To evaluate the inhibitory activity of these new compounds against various DNA polymerases, including viral reverse transcriptase, bacterial DNA polymerase, and eukaryotic DNA polymerase.
Main Methods:
- Synthesis of ten new rifamycin SV derivatives.
- Enzyme inhibition assays using purified DNA polymerases from avian myeloblastosis virus, E. coli, and calf thymus.
- Kinetic analysis (Lineweaver-Burk) to determine the mode of inhibition.
Main Results:
- One derivative, 3-(2,4,6-trinitrophenylhydrazone)-methyl rifamycin SV, strongly inhibited all tested polymerases.
- Another derivative, 3-(monoallylhydrazone)-methyl rifamycin SV, selectively inhibited viral reverse transcriptase at low concentrations.
- Kinetic studies indicated non-competitive inhibition with respect to template-primer, suggesting binding at a site distinct from the active site.
Conclusions:
- Novel rifamycin derivatives exhibit significant DNA polymerase inhibitory activity.
- Selective inhibition of viral reverse transcriptase by specific derivatives presents a promising avenue for antiviral drug discovery.
- The mechanism of action involves binding to a site other than the template-primer active site, potentially interfering with early DNA synthesis steps.